Body Fluid Balance Calculator by Inputs and Outputs

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL

حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL

حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL

حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL

حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL

حداقل ۰ — حداکثر ۲۰۰۰ • واحد: mL

حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL

حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL

حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL

حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL

حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL

حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: mL

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
fluid balance results
—mL
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Significant Negative Balance-1000–-500
  • Moderate Negative Balance-500–-200
  • Neutral Balance-200–200
  • Moderate Positive Balance200–500
Direct Clinical Answer

The Body Fluid Balance Calculator by Inputs and Outputs calculates calculating fluid balance from sodium concentrations indicating 0. Key inputs include gastric losses. Scores guide adjusting renal medication clearance, coordinating nephrology follow-up, or planning renal replacement therapy. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Calculates fluid balance from sodium concentrations indicating 0.9% saline fluid, and free water losses (GI, urine, etc) and gains (IV fluids, PO, etc). Helps track complex fluid dynamics in hospitalized patients by accounting for different sodium concentrations in various fluids.

Clinical Indication

The Body Fluid Balance Calculator by Inputs and Outputs is indicated for bedside clinical practice to support Calculates fluid balance from sodium concentrations indicating 0.9% saline fluid, and free water losses (GI, urine, etc) and gains (IV fluids, PO, etc). Helps track complex fluid dynamics in hospitalized patients by accounting for different sodium concentrations in various fluids.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute kidney injury (AKI), chronic kidney disease stages 1-5, or acid-base and fluid-electrolyte disturbances. Clinical application is indicated across Nephrology clinics, hemodialysis units, acute inpatient renal services, and metabolic wards.

Limitations & Contraindications

eGFR estimation equations assume steady-state serum creatinine and become unreliable during unstable AKI, amputations, or extremes of muscle mass.

Clinical Pearls & Action Plan

Serum creatinine lags behind acute reductions in glomerular filtration; monitor hourly urine output and consider cystatin C in evolving AKI.

Formula & Variables:

Net Fluid Balance = Total Fluid Gains - Total Fluid Losses. 0.9% Saline Balance = (Volume × Na concentration / 154) for each fluid. Free Water Balance = Volume × (1 - Na concentration / 154) for each fluid.

Input Parameters

NameTypeRequiredDescription
gastric_lossesfloatNoVolume of gastric losses in mL (sodium concentration ~60 mEq/L)(mL)
biliary_lossesfloatNoVolume of biliary losses in mL (sodium concentration ~130 mEq/L)(mL)
small_bowel_lossesfloatNoVolume of small bowel losses in mL (sodium concentration ~110 mEq/L)(mL)
diarrhea_lossesfloatNoVolume of diarrhea losses in mL (sodium concentration ~60 mEq/L)(mL)
urine_outputfloatNoVolume of urine output in mL (sodium concentration variable, typically 40 mEq/L)(mL)
insensible_lossesfloatNoEstimated insensible losses in mL (pure water loss, no sodium)(mL)
other_lossesfloatNoOther fluid losses in mL (assume isotonic, sodium ~140 mEq/L)(mL)
normal_saline_ivfloatNoVolume of 0.9% normal saline administered IV in mL (sodium 154 mEq/L)(mL)
half_normal_saline_ivfloatNoVolume of 0.45% half normal saline administered IV in mL (sodium 77 mEq/L)(mL)
lactated_ringers_ivfloatNoVolume of lactated Ringer's solution administered IV in mL (sodium 130 mEq/L)(mL)
d5w_ivfloatNoVolume of D5W (5% dextrose in water) administered IV in mL (no sodium, free water)(mL)
oral_intakefloatNoVolume of oral fluid intake in mL (assume free water)(mL)

Score Interpretation & Guidance

RangeStageDescription
-1000–-500Significant Negative BalanceNet fluid loss >500 mL
-500–-200Moderate Negative BalanceNet fluid loss 200-500 mL
-200–200Neutral BalanceNet fluid balance -200 to +200 mL
200–500Moderate Positive BalanceNet fluid gain 200-500 mL
500–2000Significant Positive BalanceNet fluid gain >500 mL

Evidence-Based References (EBM)

  • Kaptein EM, Sreeramoju D, Kaptein JS, Kaptein MJ. A systematic approach to factitious hypernatremia: A case report and review of the literature. Clin Nephrol. 2016 Apr;85(4):246-52. doi: 10.5414/CN108716.DOI: 10.5414/CN108716
  • Konstam MA, Gheorghiade M, Burnett JC Jr, et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA. 2007 Mar 28;297(12):1319-31. doi: 10.1001/jama.297.12.1319.DOI: 10.1001/jama.297.12.1319
  • Testani JM, Brisco MA, Chen J, McCauley BD, Parikh CR, Tang WH. Timing of hemoconcentration during treatment of acute decompensated heart failure and subsequent survival: importance of sustained decongestion. J Am Coll Cardiol. 2013 Aug 6;62(6):516-24. doi: 10.1016/j.jacc.2013.05.027.DOI: 10.1016/j.jacc.2013.05.027
  • Rose BD, Post TW. Clinical Physiology of Acid-Base and Electrolyte Disorders. 5th ed. New York: McGraw-Hill; 2001.

Related calculators